Stay updated on SCT: Lisdexamfetamine Trial for ADHD & SCT
Sign up to get notified when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.

Latest updates to the SCT: Lisdexamfetamine Trial for ADHD & SCT page
- ChecktodayChange DetectedThe site revision label in the footer changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe clinical trial record for lisdexamfetamine treatment of adults with ADHD and sluggish cognitive tempo is displayed, including study design, eligibility criteria, outcomes, and study documents, in place of the 403 error page.SummaryDifference45%

- Check21 days agoChange DetectedThe ClinicalTrials.gov study page remains an error page, with the footer revision changing from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to SCT: Lisdexamfetamine Trial for ADHD & SCT
Enter your email address, and we'll notify you when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.